NCT00110773 - S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Pain

Interventions

DRUG

S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%)

S-Caine Peel, composed of a 1:1 (w:w) eutectic mixture of 7% lidocaine and 7% tetracaine, applied topically. S-Caine Peel applied at approximately 1 mm in thickness and remained on the treatment area for 20 minutes (±2 minutes).

DRUG

Placebo Peel

Placebo Peel applied topically at approximately 1 mm in thickness and remained on the treatment area for 20 minutes (±2 minutes).

Trial Locations (3)

10016

Laser and Skin Surgery Center of New York, New York

20037

Washington Institute of Dermatologic Laser Surgery, Washington D.C.

48038

Midwest Cutaneous Research, Clinton Township

All Listed Sponsors

lead

ZARS Pharma Inc.

INDUSTRY